References
- Kay J, Gawkrodger DJ, Mortimer MJ, et al. The prevalence of childhood atopic eczema in a general population. J Am Acad Dermatol 1994; 3.0(1): 35–9
- Rothe MJ, Grant-Kels JM. Atopic dermatitis: an update. J Am Acad Dermatol 1996; 35(1): 1–13
- Hanifin J, Chan SC. Diagnosis and treatment of atopic dermatitis. Dermatol Ther 1996; 1: 9–18
- Firooz A, Davoudi SM, Farahmand AN, et al. Validation of the diagnostic criteria for atopic dermatitis. Arch Dermatol 1999; 135(5): 514–6
- Morren MA, Przybilla B, Bamelis M, et al. Atopic dermatitis: triggering factors. J Am Acad Dermatol 1994; 31(3 Pt 1): 467–73
- Lever R. Infection in atopic dermatitis. Dermatol Ther 1996; 1: 32–7
- Sicherer SH, Sampson HA. Food hypersensitivity and atopic dermatitis: pathophysiology, epidemiology, diagnosis, and management. J Allergy Clin Immunol 1999; 104(3 Pt 2): S114–22
- Williams HC. Do topical steroids reduce relapses in adults with atopic dermatitis? Arch Dermatol 1999; 135 (12): 1530–1
- Klein PA, Clark RA. An evidence- based review of the efficacy of antihistamines in relieving pruritus in atopic dermatitis. Arch Dermatol 1999; 135(12): 1522–5
- Ruzicka T, Bieber T, Schopf E, et al. A short-term trial of tacrolimus ointment for atopic dermatitis. European Tacrolimus Multicenter Atopic Dermatitis Study Group. N Engl J Med 1997; 337(12): 816–21
- Reitamo S, Wollenberg A, Schopf E, et al. Safety and efficacy of 1 year of tacrolimus ointment monotherapy in adults with atopic dermatitis. The European Tacrolimus Ointment Study Group. Arch Dermatol 2000 Aug; 136(8): 999–1006
- Canicci JA, Washenik K, Weinstein A, et al. The leukotriene antagonist zafirlukast as a therapeutic agent for atopic dermatitis. Arch Dermatol 1998; 134(7): 785–6
References
- Halbert AR, Weston WL, Morelli JG. Atopic dermatitis: is it an allergic disease? J Am Acad Dermatol 1995; 33(6): 1008–18
- Hanifin JM, Chan S. Biochemical and immunologic mechanisms in atopic dermatitis: new targets for emerging therapies. J Am Acad Dermatol 1999; 41(1): 72–7